Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Taiho Pharmaceutical invests $30m in Remiges BioPharma Fund Taiho Pharmaceutical, a fully-fledged oncology pharmaceutical company, has announced that the company will be investing $30m in Remiges BioPharma Fund (Remiges Fund), a newly formed biotech venture capital fund.
Production & Manufacturing > OTC > News
Purdue Pharma gets FDA approval for 7.5 mcg/hour dosage strength of Butrans transdermal system CIII Purdue Pharma has announced that the US Food & Drug Administration (FDA) has approved a new 7.5 mcg/hour dosage strength of Butrans (buprenorphine) Transdermal System CIII. Five strengths of Butrans will now be available: 5 mcg/hour, 7.5 mcg/hour, 10 mcg/hour, 15 mcg/hour and 20 mcg/hour.
Production & Manufacturing > OTC > News HPRA publishes list of potential medicines to be sold without prescription The Health Products Regulatory Authority (The HPRA), formerly the Irish Medicines Board (IMB), published a list of 12 active substances contained in medicines currently classified as prescription-only medicines (POM) which could be safely reclassified and switched to over the counter (OTC) sale.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
CVS/pharmacy launches exclusive radiance PLATINUM line of preservative-free vitamins and supplements
CVS/pharmacy has announced the introduction of radiance PLATINUM, a premium brand of 100% preservative-free vitamins and supplements and the latest addition to the growing family of exclusive CVS/pharmacy store brand products.
Production & Manufacturing > OTC > News
Makers of OTC medicines respond to pediatrics study on units of measurement on liquid medicines
The Consumer Healthcare Products Association (CHPA) released the following statement today in response to the Pediatrics study “Unit of Measurement Used and Parent Medication Dosing Errors,” which found that parents who used milliliter-only units made fewer dosing errors than those who used teaspoon or tablespoon units.
Production & Manufacturing > OTC > News
Upsher-Smith launches generic equivalent to Qudexy XR extended-release capsules
Upsher-Smith Laboratories (Upsher-Smith), has announced the launch of Topiramate Extended-Release Capsules, the authorized generic of the recently Food and Drug Administration (FDA) approved Qudexy XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile.
Production & Manufacturing > OTC > News
Actavis confirms generic Diclegis patent challenge
Actavis has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-release tablets, 10 mg/10 mg.
Production & Manufacturing > OTC > News
Verde Media to launch proprietary deep well fermentation technology for Omega-3 production in Asia
Verde Media, through its Verde Media Biotechnology Division is preparing for the next phase of construction for its Pilot and semi-commercial Omega-3 oil production facility in Asia. The company broke ground on the project in May of this year and is currently poised to begin building the most crucial and cost-effective part of the facility.
Production & Manufacturing > OTC > News
Perrigo gets FDA final approval for store brand equivalent to Advil congestion relief tablets
By PBR Staff Writer
Ireland-based Perrigo Company has received final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil Congestion Relief Tablets, 200 mg/10 mg.
Production & Manufacturing > OTC > News
Actavis confirms generic Ampyra patent challenge
Actavis has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market Dalfampridine Extended-release Tablets, 10 mg.
Production & Manufacturing > OTC > News
GelStat acquires Mastix Medica for restricted common stock
GelStat Corporation (GSAC), a company engaged in the research, development, marketing, licensing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce it has closed the acquisition of Mastix Medica, on July 7, 2014.
Production & Manufacturing > OTC > News
NutraFuels plans to introduce TapouT XT extreme energy oral spray
By PBR Staff Writer
NutraFuels, a US-based manufacturer of oral spray dietary supplements, is planning to launch its latest product, TapoutT XT Extreme Energy Oral Spray in August 2014.
Production & Manufacturing > OTC > News
Actavis completes acquisition of Forest Laboratories
Actavis has completed the acquisition of Forest Laboratories in a cash and equity transaction currently valued at approximately $28bn.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250